Literature DB >> 27169398

The results of a survey of physicians about the Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 and its clinical use.

Masaki Mogi1, Naoyuki Hasebe2, Masatsugu Horiuchi1, Kazuaki Shimamoto3, Satoshi Umemura4.   

Abstract

The current study investigated physicians' awareness and use of the Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 (JSH2014) and is based on the results of a survey performed by the Publicity and Advertisement Committee of JSH. A questionnaire was used to survey physicians' awareness of the JSH2014, their recommended target blood pressure for hypertensive patients with complications and their use of antihypertensive drugs. Physicians who downloaded a PDF version of JSH2014 during the 6 months after its publication (April-September 2014) were asked to complete an online questionnaire. Of the 7872 respondents, 91% were aware of the JSH and complied partially, mostly or completely with it in their practice. With reference to hypertensive patients, ∼70% of physicians who completed the questionnaire recommended a target blood pressure (BP) of 140/90 mm Hg for an office BP value, and 40% recommended 135/85 mm Hg for a home BP value. Physicians recommended target BP levels of 130/80 mm Hg for patients with diabetes or chronic kidney disease (50-63% of physician surveyed) and for elderly patients with diabetes or kidney disease (45-55% of respondents), whereas they recommended 140/90 mm Hg for elderly patients with low cardiovascular disease risk (56-60% of physician surveyed) and for patients with chronic-phase stroke (40-47% of respondents). The most commonly prescribed combination of antihypertensive drugs was angiotensin receptor blocker (ARB) with calcium channel blocker. In addition, physicians' first choice of drug for patients with diabetes or chronic kidney disease was most often ARB. Overall, the survey results showed that the new recommendations from the JSH2014 accurately reflect daily clinical practices for hypertension management used by Japanese physicians.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27169398     DOI: 10.1038/hr.2016.42

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  8 in total

1.  Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Iryna Lobach; Franz H Messerli
Journal:  Circulation       Date:  2011-05-31       Impact factor: 29.690

2.  Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension and their use in clinical practices: 2009 survey results.

Authors:  Taku Obara; Sergio Ramón Gutiérrez Ubeda; Takayoshi Ohkubo; Hideo Matsuura; Toshihiko Ishimitsu; Masanobu Takata; Hiromi Rakugi; Yutaka Imai
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

Review 3.  Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Authors:  Lars Hjalmar Lindholm; Bo Carlberg; Ola Samuelsson
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

4.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).

Authors:  Kazuaki Shimamoto; Katsuyuki Ando; Toshiro Fujita; Naoyuki Hasebe; Jitsuo Higaki; Masatsugu Horiuchi; Yutaka Imai; Tsutomu Imaizumi; Toshihiko Ishimitsu; Masaaki Ito; Sadayoshi Ito; Hiroshi Itoh; Hiroshi Iwao; Hisashi Kai; Kazuomi Kario; Naoki Kashihara; Yuhei Kawano; Shokei Kim-Mitsuyama; Genjiro Kimura; Katsuhiko Kohara; Issei Komuro; Hiroo Kumagai; Hideo Matsuura; Katsuyuki Miura; Ryuichi Morishita; Mitsuhide Naruse; Koichi Node; Yusuke Ohya; Hiromi Rakugi; Ikuo Saito; Shigeyuki Saitoh; Kazuyuki Shimada; Tatsuo Shimosawa; Hiromichi Suzuki; Kouichi Tamura; Norio Tanahashi; Takuya Tsuchihashi; Makoto Uchiyama; Shinichiro Ueda; Satoshi Umemura
Journal:  Hypertens Res       Date:  2014-04       Impact factor: 3.872

5.  Practice and awareness of physicians regarding home blood pressure measurement in Japan.

Authors:  Taku Obara; Takayoshi Ohkubo; Hidefumi Fukunaga; Mitsuru Kobayashi; Michihiro Satoh; Hirohito Metoki; Kei Asayama; Ryusuke Inoue; Masahiro Kikuya; Nariyasu Mano; Masaaki Miyakawa; Yutaka Imai
Journal:  Hypertens Res       Date:  2010-02-26       Impact factor: 3.872

6.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

7.  Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis.

Authors:  Kerry McBrien; Doreen M Rabi; Norm Campbell; Lianne Barnieh; Fiona Clement; Brenda R Hemmelgarn; Marcello Tonelli; Lawrence A Leiter; Scott W Klarenbach; Braden J Manns
Journal:  Arch Intern Med       Date:  2012-09-24

8.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

  8 in total
  8 in total

1.  Determinants of short and long door-to-balloon time in current primary percutaneous coronary interventions.

Authors:  Takunori Tsukui; Kenichi Sakakura; Yousuke Taniguchi; Kei Yamamoto; Hiroshi Wada; Shin-Ichi Momomura; Hideo Fujita
Journal:  Heart Vessels       Date:  2017-11-20       Impact factor: 2.037

2.  Current Practice of Hypertension in India: Focus on Blood Pressure Goals.

Authors:  Jagdish S Hiremath; Vijay M Katekhaye; Vijay S Chamle; Rishi M Jain; Amit I Bhargava
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 3.  Strategies for improving the treatment and control of hypertension in Japan.

Authors:  Atsushi Sakima; Tetsutaro Matayoshi; Hisatomi Arima
Journal:  J Hum Hypertens       Date:  2022-06-03       Impact factor: 3.012

4.  Relationship of Annual Health Checkups with the Subject's Subsequent Behavior of Cardiovascular Risk Management in a Real-World Setting in Japan: A Retrospective Cohort Study on Changes in Antihypertensive Drug Prescription and Blood Pressure from 2015 to 2017.

Authors:  Shingo Higa; Yoichi Ii; Kazutaka Nozawa; Yuji Yamamoto; Kazuhiro Ohwaki; Yuko Asami
Journal:  Drugs Real World Outcomes       Date:  2021-01-15

5.  Effects of eplerenone on blood pressure and glucose metabolism in Japanese hypertensives with overweight or obesity.

Authors:  Hisashi Adachi; Tatsuyuki Kakuma; Machiko Kawaguchi; Eita Kumagai; Yoshihiro Fukumoto
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Factors associated with diabetic polyneuropathy-related sensory symptoms and signs in patients with polyneuropathy: A cross-sectional Japanese study (JDDM 52) using a non-linear model.

Authors:  Hiroki Yokoyama; Toshinaga Tsuji; Shinji Hayashi; Daijiro Kabata; Ayumi Shintani
Journal:  J Diabetes Investig       Date:  2019-08-06       Impact factor: 4.232

7.  Perspectives of patients and physicians regarding hypertensive management from an online survey for excellence: a subanalysis of the PARADOX study by physician categories.

Authors:  Takuo Yoshida; Nobuhiro Nishigaki; Shun Saita; Yukio Shimasaki; Naoyuki Hasebe
Journal:  Hypertens Res       Date:  2020-01-29       Impact factor: 3.872

8.  Recent changes in blood pressure levels, hypertension prevalence and treatment rates, and the rate of reaching target blood pressure in the elderly.

Authors:  Hiroyuki Takase; Takamitsu Tanaka; Shin Takayama; Daishi Nonaka; Masashi Machii; Tomonori Sugiura; Sumiyo Yamashita; Nobuyuki Ohte; Yasuaki Dohi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.